Linee Guida / Raccomandazioni - internazionali
| PATOLOGIA | CRITERI/RACCOMANDAZIONI | DATA | NOME | LINK |
|---|---|---|---|---|
| ARTERITE A CELLULE GIGANTI | EULAR | 2009 | EULAR recommendations for the management of large vessel vasculitis | link |
| ACR | 1990 | Criteria for the classification of Giant Cell (temporal) Arteritis | link | |
| ARTRITE IDIOPATICA GIOVANILE | ACR | 2011 | 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features | link |
| International League of Associations for Rheumatology | 2004 | International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 | link | |
| ARTRITE PSORIASICA | EULAR | 2012 | European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies | link Ann Rheum Dis 2012;71:4-12 doi:10.1136/annrheumdis-2011-200350 |
| GRAPPA | 2008 | Treatment recommendations for psoriatic arthritis | link | |
| CASPAR | 2006 | CASPAR Study Group Criteria for PsA | link Arthritis Rheum 2006;54:2665–73 |
|
| ARTRITE REUMATOIDE | EULAR | 2012 | EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis | link Ann Rheum Dis 2012;71:638-641 doi:10.1136/annrheumdis-2011-200990 |
| ACR | 2012 | 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis |
link Arthritis Care & Research Vol. 64, No. 5, May 2012, pp 625– 639 |
|
| ACR/EULAR | 2011 | American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials | link Ann Rheum Dis 2011;70:404-413 doi:10.1136/ard.2011.149765 |
|
| EULAR | 2011 | EULAR 2011 Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative | link Ann Rheum Dis 2011;70:935-942 doi:10.1136/ard.2010.142901 |
|
| ACR/EULAR | 2010 | 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative | link Ann Rheum Dis 2010;69:1580-1588 doi:10.1136/ard.2010.138461 |
|
| ACR/EULAR | 2010 | Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations | link Ann Rheum Dis., Oct 2008; 67: 1360 - 1364 |
|
| EULAR | 2010 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | link Ann Rheum Dis Published Online First: 5 May 2010 doi:10.1136/ard.2009.126532 |
|
| EULAR | 2010 | EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | link Ann Rheum Dis, Feb 2010; 69: 325-331 |
|
| EULAR | 2010 | EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | link Ann Rheum Dis, Nov 2009; 68: 1680-1685 |
|
| EULAR | 2009 | Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative | link | |
| ACR | 2008 | 2008 Recommendations for the Use of Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis | link | |
| ACR | 2002 | Guidelines for the management of rheumatoid arthritis: 2002 update | link | |
| ACR | 1987 | 1987 Criteria for the Classification of Acute Arthritis of Rheumatoid Arthritis | link | |
| ARTROSI | ACR | 2012 | American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee | link Arthritis Care & Research Vol. 64, No. 4, April 2012, pp 465– 474 |
| EULAR | 2010 | EULAR evidence based recommendations for the diagnosis of knee osteoarthritis | link Ann Rheum Dis, Mar 2010; 69: 483 - 489 |
|
| OARSI | 2010 | OARSI recommendations for management of hip and knee osteoarthritis: Part III, changes in evidence 2010 | link | |
| EULAR | 2009 | EULAR evidence based recommendations for the diagnosis of hand osteoarthritis - report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) | link Ann Rheum Dis, Jan 2009; 68: 8 - 17 |
|
| OARSI | 2007 | OARSI recommendations for management of hip and knee osteoarthritis: Part II: OARSI evidence-based, expert consensus guidelines | link | |
| ACR | 2000 | Recommendation for the Medical Management of Osteoarthritis of the Hip and Knee | link | |
| ACR | 1991 | The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip | link | |
| ACR | 1990 | The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand | link | |
| ACR | 1986 | Developing criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee | link | |
| MALATTIA DI BEHCET | EULAR | 2008 | EULAR recommendations for the management of Behçet disease | link Ann Rheum Dis, Dec 2008, 67: 1656-1662 |
| International Study Group for Behçet's Disease | 1990 | Criteria for diagnosis of Behçet's disease | link | |
| CONDROCALCINOSI | EULAR | 2011 | European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis | link Ann Rheum Dis 2011;70:563-570 |
| EULAR | 2011 | EULAR recommendations for calcium pyrophosphate deposition. Part II: Management | link Ann Rheum Dis 2011;70:571-575 |
|
| DERMATOMIOSITE/ POLIMIOSITE | Bohan and Peter | 1975 | Polymyiositis and Dermatomyositis Classification Criteria | Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344–7. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; |
| FIBROMIALGIA | ACR | 2010 | The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity | link |
| EULAR | 2008 | EULAR evidence based recommendations for the management of fibromyalgia syndrome | link Ann Rheum Dis, Apr 2008; 67: 536-541 |
|
| ACR | 1990 | The American College of Rheumatology 1990 criteria for the classification of Fibromyalgia | link | |
| GOTTA | EULAR | 2006 | Eular evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) | link Ann Rheum Dis, Oct 2006; 65: 1301 - 1311 |
| EULAR | 2006 | EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) | link Ann Rheum Dis, Oct 2006; 65: 1312 - 1324 |
|
| LUPUS ERITEMATOSO SISTEMICO | ACR | 2012 | American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis | link Arthritis Care & Research Vol. 64, No. 6, June 2012, pp 797– 808 |
| EULAR | 2010 | EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs | link Ann Rheum Dis doi:10.1136/ard.2010.130476 |
|
| EULAR | 2010 | EULAR Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies | link Ann Rheum Dis. Jul 2010; 69: 1269-1274 |
|
| EULAR | 2009 | EULAR points to consider for conducting clinical trials in systemic lupus erythematosus | link Ann Rheum Dis., April 2009; 68: 470 - 476 |
|
| EULAR | 2008 | EULAR recommendations for the management of systemic lupus erytematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) | link Ann Rheum Dis, Feb 2008; 67: 195-205 |
|
| ACR | 1999 | Guidelines for Referral and Management of Systemic Lupus Erythematosus in Adults | link | |
| ACR | 1997 | 1997 Update of the 1982 American College of Rheumatology Revised Criteria for Classification of Systemic Lupus Erythematosus | link | |
| OSTEOPOROSI | ECTS | 2012 | A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis |
link |
| Endocrine Society | 2012 | Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline | link The Journal of Clinical Endocrinology & Metabolism. June 1, 2012 vol. 97 no. 6 1802-1822 |
|
| SIOMMMS | 2012 | Linee guida per la diagnosi, prevenzione e terapia dell’Osteoporosi (aggiornamento 2012) | link | |
| SIOMMMS | 2011 | Linee guida su prevenzione e trattamento dell'ipovitaminosi D con colecalciferolo |
link | |
| ACR/ASBMR | 2010 | 2010 Recommendations for the Management of Glucocorticoid-Induced Osteoporosis | link | |
| SIOMMMS | 2009 | Linee guida per la diagnosi, prevenzione e terapia dell’osteoporosi | link | |
| SIOMMMS/ANDI | 2009 | Raccomandazioni relative all’osteonecrosi della mascella/mandibola associata a terapia con bisfosfonati in pazienti con osteoporosi: documento di consenso | link | |
| MORBO DI PAGET | SIOMMMS | 2007 | Linee guida per la diagnosi e la terapia del morbo di Paget | link |
| POLIMIALGIA REUMATICA | EULAR/ACR | 2012 | 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative | link Ann Rheum Dis 2012;71:484-492 doi:10.1136/annrheumdis-2011-200329 |
| EULAR | 2003 | EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT) | link Ann Rheum Dis, Dec 2003; 62: 1189 - 1194 |
|
| SJOGREN | ACR | 2012 | American College of Rheumatology Classi?cation Criteria for Sjogren’s Syndrome: A Data-Driven, Expert Consensus Approach in the Sjogren’s International Collaborative Clinical Alliance Cohort |
link Arthritis Care & Research Vol. 64, No. 4, April 2012, pp 475– 487 |
| EULAR | 2010 | EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI): Development of a consensus systemic disease activity index in primary Sjögren's syndrome | link Ann Rheum Dis, June 2010; 69: 1103-1109 |
|
| SPONDILITE ANCHILOSANTE | EULAR | 2011 | 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis | link Ann Rheum Dis 2011;70:896-904 doi:10.1136/ard.2011.151027 |
| EULAR | 2009 | ASAS/EULAR recommendations for the management of ankylosing spondylitis - the patient version | link Ann Rheum Dis, Sept 2009; 68: 1381-1386 |
|
| EULAR | 2006 | ASAS/EULAR recommendations for the management of ankylosing spondylitis | link | |
| SSC | EULAR | 2009 | EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) | link Ann Rheum Dis, May 2009; 68: 620-628 |
| ACR | 1995 | Guidelines for Clinical Trials in Systemic Sclerosis (Scleroderma) | link | |
| ACR | 1980 | Criteria for the classification of systemic sclerosis | link | |
| TERAPIA STEROIDEA | EULAR | 2010 | Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice | link Ann Rheum Dis Published Online First: 6 August 2010 doi:10.1136/ard.2009.124958 |
| EULAR | 2007 | EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases | link Ann Rheum Dis, Dec 2007; 66: 1560-1567 |
|
| VASCULITI | EULAR | 2010 | EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis | link Ann Rheum Dis 2010;69:1744-1750 doi:10.1136/ard.2009.119032 |
| EULAR | 2009 | EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria | link Ann Rheum Dis 2010;69; 69: 798 - 806 |
|
| EULAR | 2009 | EULAR recommendations for the management of primary small and medium vessel vasculitis | link | |
| EULAR | 2007 | EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on ANCA-associated vasculitis | link Ann Rheum Dis, May 2007; 66: 605 - 617 |
|
| EULAR | 2006 | EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides | link Ann Rheum Dis, Jul 2006; 65: 936 - 941 |
|
| ACR | 1990 | The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. | link | |
| ACR | 1990 | 1990 Criteria for the Classification of Churg-Strauss Syndrome | link | |
| ACR | 1990 | 1990 Criteria for the Classification of Polyarteritis Nodosa | link | |
| ACR | 1990 | 1990 Criteria for the Classification of Wegener’s Granulomatosis | link | |
| VARIE | EULAR | 2012 | EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis | link |
| EULAR | 2011 | EULAR recommendations for vaccination in paediatric patients with rheumatic diseases | link | |
| EULAR | 2011 | EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases | link |